日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Methodological Considerations in Evaluating CTRP12 as a Biomarker for In-Stent Restenosis

评估 CTRP12 作为支架内再狭窄生物标志物的方法学考虑

Khattak, Saleha; Rayyan, Syed Muhammad; Khan, Syed Huzaifa

Advancing Equity in Left Atrial Appendage Occlusion Outcomes for Hispanic/Latino Patients

提升西班牙裔/拉丁裔患者左心耳封堵术治疗结果的公平性

Rayyan, Syed Muhammad; Ameer, Bakhtiyar; Iqbal, Mueed; Khan, Muhammad Abdul Haseeb; Khan, Farmanullah

Case Ascertainment and Exposure Classification in Acute Myocardial Infarction Mortality Studies Involving Psychoactive Substance Use

涉及精神活性物质使用的急性心肌梗死死亡率研究中的病例确定和暴露分类

Haider, Noor-Ul-Eman; Rayyan, Syed Muhammed; Abbas, Muhammad

Revisiting the Boundaries of GDMT Optimization: Beyond Adverse Effects and Into the Future of Personalized Heart Failure Care

重新审视指南指导药物治疗优化的边界:超越不良反应,迈向个性化心力衰竭治疗的未来

Rehman, Ateeq Ur; Rayyan, Syed Muhammad; Khan, Areeba

Critique on "Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification"

对“使用 EHRA(评估心脏瓣膜,风湿性或人工)分类评估房颤患者是否存在原生瓣膜疾病”的评论

Javed, Arooha; Savez, Syed Muhammad; Rayyan, Syed Muhammad

Emrelis (telisotuzumab vedotin-tllv): targeting C-MET in non-small cell lung cancer

Emrelis(telisotuzumab vedotin-tllv):靶向 C-MET 治疗非小细胞肺癌

Khan, Muhammad Abdul Haseeb; Ahmad, Waleed; Ehsan, Hedayatullah; Iqbal, Mueed; Rayyan, Syed Muhammad; Mehrpoor, Ahmad Jamshid

Importance of Incorporating the Perspectives of People with Cancer into Oncology Education: A Scoping Review

将癌症患者视角纳入肿瘤学教育的重要性:一项范围界定综述

Dutt, Hanna; Dean, Arleigh; Kamal, Rayyan Syed; Allan, Alison L

Hypoglycemia as first presentation of presumed immune checkpoint inhibitor-induced type 1 diabetes

低血糖症可能是免疫检查点抑制剂诱发的1型糖尿病的首发表现

Kamal, Rayyan Syed; Dean, Arleigh; Dutt, Hanna; Rajeh, Adnan; Fernandes, Ricardo